
1. int j antimicrob agents. 2014 aug;44(2):117-24. doi:
10.1016/j.ijantimicag.2014.04.020. epub 2014 jun 14.

culturomics pyrosequencing evidence reduction gut microbiota
diversity patients broad-spectrum antibiotics.

dubourg g(1), lagier jc(1), robert c(2), armougom f(2), hugon p(1), metidji s(2),
dione n(2), dangui np(2), pfleiderer a(2), abrahao j(3), musso d(4), papazian
l(5), brouqui p(1), bibi f(6), yasir m(6), vialettes b(7), raoult d(8).

author information: 
(1)aix-marseille university, unité de recherche sur les maladies infectieuses et 
tropicales emergentes (urmite; research unit infectious tropical emerging 
diseases) um 63 cnrs 7278 ird 198 inserm u1095, faculties medicine and
pharmacy, marseille, france; pôle des maladies infectieuses et tropicales
clinique et biologique, fédération de bactériologie-hygiène-virologie,
university, hospital centre timone, institut hospitalo-universitaire (ihu)
méditerranée infection, assistance publique-hôpitaux de marseille, marseille,
france.
(2)aix-marseille university, unité de recherche sur les maladies infectieuses et 
tropicales emergentes (urmite; research unit infectious tropical emerging 
diseases) um 63 cnrs 7278 ird 198 inserm u1095, faculties medicine and
pharmacy, marseille, france.
(3)departamento de microbiologia, laboratório de vírus, universidade federal de
minas gerais, belo horizonte, minas gerais, brazil.
(4)institut louis malardé, pape'ete, tahiti, french polynesia.
(5)aix-marseille university, unité de recherche sur les maladies infectieuses et 
tropicales emergentes (urmite; research unit infectious tropical emerging 
diseases) um 63 cnrs 7278 ird 198 inserm u1095, faculties medicine and
pharmacy, marseille, france; service de réanimation médicale-détresse
respiratoires et infections sévères-hôpital nord, chemin des bourrely, 13015
marseille, france.
(6)special infectious agents unit, king fahd medical research center, king
abdulaziz university, jeddah 21589, saudi arabia.
(7)service de nutrition, hôpital timone, 13005 marseille, france.
(8)aix-marseille university, unité de recherche sur les maladies infectieuses et 
tropicales emergentes (urmite; research unit infectious tropical emerging 
diseases) um 63 cnrs 7278 ird 198 inserm u1095, faculties medicine and
pharmacy, marseille, france; pôle des maladies infectieuses et tropicales
clinique et biologique, fédération de bactériologie-hygiène-virologie,
university, hospital centre timone, institut hospitalo-universitaire (ihu)
méditerranée infection, assistance publique-hôpitaux de marseille, marseille,
france; special infectious agents unit, king fahd medical research center, king
abdulaziz university, jeddah 21589, saudi arabia. electronic address:
didier.raoult@gmail.com.

the human gut flora currently widely characterised using molecular techniques.
microbial culturomics (large-scale culture conditions identification of
colonies using maldi-tof 16s rrna) part rebirth bacterial culture
that initiated environmental microbiologists design axenic
culture intracellular bacteria clinical microbiology. culturomics was
performed four stool samples patients treated large-scale
antibiotics assess diversity gut flora comparison other
culture-dependent studies. pyrosequencing v6 region also performed and
was compared control group. gut richness also estimated bacterial
counting microscopic observation. total, 77 culture conditions were
tested 32,000 different colonies generated; 190 bacterial species were
identified, 9 species isolated human gut before
this study, 7 newly described humans 8 completely new species. dramatic 
reduction diversity observed two four stool samples which
antibiotic treatment prolonged uninterrupted. total number of
bacteria generally preserved, suggesting original population was
replaced sustained size. discordances culture and
pyrosequencing biodiversity biomarkers highlight depth bias molecular
studies. stool samples studied showed dramatic reduction bacterial
diversity. considering variable antibiotic concentration gut, this
reduction number species possibly linked production of
bacteriocin upper digestive tract specific bacteria, as
lactobacillus spp.

copyright © 2014 elsevier b.v. international society chemotherapy. all
rights reserved.

doi: 10.1016/j.ijantimicag.2014.04.020 
pmid: 25063078  [indexed medline]

